Single-domain antibodies represent novel alternatives to monoclonal antibodies as targeting agents against the human papillomavirus 16 E6 protein
M. Togtema, G. Hussack, G. Dayer, M. Teghtmeyer, S. Raphael, J. Tanha, I. Zehbe
This study identifies VHHs that bind HPV16 E6 protein with nanomolar affinity, offering potential as novel targeting agents for HPV16-related cancers.
bioRxiv · Aug 9, 2018Cancer Biology